Other medications like Xenical, which reduces the absorption of fat, may be a good fit for people who are looking to reduce their calorie intake or who might not tolerate the GLP-1 drugs
Results: Of the 163 HAE-C1-INH patients, 143 had HAE-C1-INH-Type1 and 20 had HAE-C1-INH-Type2
Tirzepatide may produce greater average weight loss for some individuals because it activates two hormone pathways, GLP-1 and GIP, while semaglutide targets only the GLP-1 receptor
At Meto, we work with patients on both these medications regularly, and the difference between an FDA-approved GLP-1 and an uncharacterized compounded peptide is not minor it is fundamental
Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 17.99 / 30 days cancel any time Subscribe to this journal Receive 52 print issues and online access 199.00 per year only 3.83 per issue Rent or buy this article Prices vary by article type from$1.95 to$39.95 Prices may be subject to local taxes which are calculated during checkout Nature 629 , 1011-1012 (2024) doi: References Petersen, J
